A group of students sits in an auditorium listening to a lecture.

New Berkeley pedagogy course introduces the science of teaching

Research shows that certain teaching practices improve learning and reduce inequities. Graduate student Eva Gerber explores how one UC Berkeley department is bringing these crucial findings from education journals into classrooms. By the time that Danielle Spitzer, a fifth-year graduate student in the department of Molecular and Cell Biology (MCB), attended her departmental first-time Graduate…

QB3 workforce development programs receive $5 million state funding boost

The State of California allotted $20 million in this year’s budget to QB3 and its sibling California Institutes for Science and Innovation to plan and implement programs to strengthen and grow the workforce. QB3 will use its share — $5 million over five years — to provide students with training in advanced biotechnology, and to…

Image of the Arc Institute building at sunset

UC Berkeley partners with new Arc Institute to tackle complex diseases

UC Berkeley is partnering with UC San Francisco and Stanford University as founding scientific members of a new institute that aims to accelerate breakthroughs in complex diseases. The Arc Institute was officially launched today (Dec. 15) with the goal of developing a new model for collaborative research that brings together world-class research with unconstrained funding…

Lost in translation

Graduate student Leah Gulyas explores how one tiny coronavirus protein blockades host cells—and how a few simple changes can flip the script. Mission control! Mission control! Do you read me? While these lines might first bring to mind a movie scene of astronauts frantically trying to contact their home base following a disastrous event in…

$17 million will launch trial of CRISPR cure for sickle cell disease

A small clinical trial of a CRISPR cure for sickle cell disease, approved earlier this year by the U.S. Food and Drug Administration, has received $17 million to enroll about nine patients, the first of which may be selected before the end of the year.